Oncocross Co., Ltd. (KOSDAQ:382150)
South Korea · Delayed Price · Currency is KRW 9,970.00
-150.00 (-1.48%)
Sep 19, 2025, 3:30 PM KST
Oncocross Market Cap
Oncocross has a market cap or net worth of 119.82 billion as of September 19, 2025.
Market Cap
119.82B
Enterprise Value
103.86B
Revenue
1.04B
Ranking
n/a
PE Ratio
n/a
Stock Price
9,970.00
Market Cap Chart
Since December 18, 2024, Oncocross's market cap has increased from 106.25B to 119.82B, an increase of 12.77%. That is a compound annual growth rate of 17.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2025 | 119.82B | 59.38% |
| Dec 30, 2024 | 75.18B | -29.24% |
| Dec 18, 2024 | 106.25B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.24T |
| Celltrion | 37.10T |
| ALTEOGEN | 25.28T |
| Yuhan | 8,752.85B |
| SK Biopharmaceuticals | 8,410.84B |
| Peptron | 6,744.58B |
| PharmaResearch | 6,431.19B |
| ABL Bio | 5,452.05B |